Projects per year
Project Details
Description
This is a randomized, within-group crossover, double-blind, placebo controlled phase I/II study of single ascending oral doses of 20, 80 and 160mg of NPS R-568. The drug, a calcimimetic agent which suppresses Parathyroid hormone secretion, will be given to postmenopausal women with primary hyperparathyroidism, a disease with no currently available medical therapy.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/96 → 9/30/98 |
Funding
- National Center for Research Resources
ASJC Scopus Subject Areas
- Medicine(all)
- Endocrinology, Diabetes and Metabolism
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
GENERAL CLINICAL RESEARCH CENTER
Tapley, D. (PI), Morris, T. (PI), Colten, H. (PI) & Al-Awqati, Q. (CoPI)
National Center for Research Resources
12/1/84 → 9/29/06
Project: Research project